Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alkes A. Khotko"'
Autor:
Andrey L. Bakulev, Olga A. Pritulo, Zhanna S. Kuntsevich, Alkes A. Khotko, Anastasiya A. Yunovidova, Pavel V. Gorognichev, Oleg R. Ziganshin, Natalya S. Rudneva, Evgeniya V. Bildyuk, Tatiana V. Repina, Valentina Y. Dudko, Mariya D. Maksimova
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 99, Iss 5, Pp 84-95 (2023)
Rationale. Data from randomized clinical trials (RCTs) may differ from the results of the efficacy and safety of medicines in the conditions of daily work. Purpose. To obtain data on the long-term efficacy and safety of the use of the genetically
Externí odkaz:
https://doaj.org/article/f6a5cd60fbb64a938817a2062f15e986
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 96, Iss 1, Pp 58-66 (2020)
Psoriasis is a chronic immune-mediated disease with predominant damage to the skin and musculoskeletal system. This paper describes the clinical manifestations of psoriasis requiring a special therapeutic approach. The profiles of patients who sho
Externí odkaz:
https://doaj.org/article/851ca5984d9b456b8b26dbf885c70928
Autor:
Alexey V Samtsov, Andrey L Bakulev, Vladislav R Khairutdinov, Muza M Kokhan, Tat'yana V Korotaeva, Iskander K Minullin, Olga A Vylegzhanina, Valery V Dubenskiy, Bulat V Khalilov, Alkes A Khotko, Olga S Zykova, Irina V Chumachenko, Alexander M Lukyanov, Antonina V Artemeva, Polina P Pukhtinskaia
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263214 (2022)
IntroductionThe objective of this study was to demonstrate that BCD-057 is similar to innovator adalimumab (iADA) in terms of efficacy, safety, and pharmacokinetics in steady state in the target population of patients with moderate to severe plaque p
Externí odkaz:
https://doaj.org/article/6921fd4a710d4aa59c40eb18d78e4463
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 96, Iss 1, Pp 58-66 (2020)
Psoriasis is a chronic immune-mediated disease with predominant damage to the skin and musculoskeletal system. This paper describes the clinical manifestations of psoriasis requiring a special therapeutic approach. The profiles of patients who showed
Autor:
Odnopozova L; Alliance Biomedical Ural Group, 89 ul. 10 Let Oktyabrya st, Izhevsk, Udmurtskaya Respublika, 426061, Russian Federation. lodnopozova@abug.su., Edin A; LLC ArsVitae Severo-Zapad, St. Petersburg, Russia., Sukharev A; Clinic of Dermatology and Venerology, St. Petersburg, Russia., Wu T; AbbVie Inc., North Chicago, IL, USA., Aydin K; AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany., Kelly M; AbbVie Inc., North Chicago, IL, USA., Khotko A; GBUZ Clinical Dermatovenerology, Dispensary of MoH of Krasnodar Region, Krasnodar, Russia.
Publikováno v:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2022 Sep; Vol. 12 (9), pp. 2063-2075. Date of Electronic Publication: 2022 Aug 02.